108Labs launches Colostrupedics whole-human infant formula with secretory antibodies

By Jim Cornall contact

- Last updated on GMT

First electron micrograph of 108Labs' secretory antibodies. Pic: 108Labs
First electron micrograph of 108Labs' secretory antibodies. Pic: 108Labs

Related tags: HMO, Infant formula

US-based 108Labs has announced the discovery of novel secretory antibody biosynthesis in the development of Colostrupedics whole-human infant formula.

Colostrupedics is the first animal-free infant formula comprising cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.

Since 2013, 108Labs has worked on mammary cell agriculture by developing the first infant formula biosimilar to mother’s milk with secretory antibodies.

"Whole-human" infant formula is made with human molecules produced with human cells. It is formulated with patent-pending human cell-cultured ingredients comprising complex sugars, probiotic HMO, bioactive human proteins, and calorically-dense human lipids naturally evolved in mothers.

The company said its whole-human infant formula contains a healthier amino-acid pattern, fully human protein sequences, and human oligosaccharides missing from bovine formula.

"After a long journey, it is an exciting day to emerge with such an innovative product vision and major scientific milestones behind us,”​ said Shayne Giuliano, co-founder and CEO of 108Labs.

“108Labs has long dreamed of a day when mothers do not have to compromise on nutritional or antimicrobial benefits when deciding how to feed their newborns. Launching Colostrupedics whole-human infant formula with the world’s first human secretory antibody ingredient is a major step in our mission to replace bovine with healthier whole-human milk worldwide by 2040."

108Labs is running pre-clinical safety and efficacy studies in preparation for infant nutritional trials with 108Labs’ Colostrupedics whole-human infant formula.

Related topics: Manufacturers, Nutritionals

Related news

Follow us

Products

View more

Webinars